KPF
BLU

K2 Principal Fund’s BELLUS Health Inc. BLU Stock Holding History

K2 Principal Fund’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-116,470
Closed -$264K – 372
2020
Q3 		$264K Buy
+116,470
New +$330K 0.04% 213

Other funds holding BLU

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

K2 Principal Fund's BLU Position: Q4 2020 in Review

K2 Principal Fund sold out of BELLUS Health Inc. (BLU) in Q4 2020, closing a stake of 116,470 shares — an estimated $264K sold.

K2 Principal Fund first reported a position in BLU in Q3 2020 and held it in 1 quarter. The position peaked at $264K in Q3 2020. 46 funds tracked by Wall St. Rank hold BLU as of Q4 2020.

  • K2 Principal Fund reported no remaining BELLUS Health Inc. position as of Q4 2020 after selling out during the quarter.
  • K2 Principal Fund sold 116,470 BELLUS Health Inc. shares in Q4 2020, an estimated $264K.
  • K2 Principal Fund first reported a position in BELLUS Health Inc. in Q3 2020 and held it in 1 quarter.
  • K2 Principal Fund's BELLUS Health Inc. position peaked at $264K in Q3 2020.
  • 46 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q4 2020.

Based on K2 Principal Fund's 13F filing for Q4 2020, filed 12 Feb 2021.